Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Towa Pharmaceutical Total Liabilities (Quarterly) : 1.835B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.835B |
| March 31, 2026 | 1.868B |
| December 31, 2025 | 1.909B |
| September 30, 2025 | 2.036B |
| June 30, 2025 | 2.094B |
| March 31, 2025 | 2.001B |
| December 31, 2024 | 1.845B |
| September 30, 2024 | 1.984B |
| June 30, 2024 | 1.792B |
| March 31, 2024 | 1.815B |
| December 31, 2023 | 1.886B |
| September 30, 2023 | 1.649B |
| June 30, 2023 | 1.731B |
| March 31, 2023 | 1.762B |
| December 31, 2022 | 1.664B |
| September 30, 2022 | 1.471B |
| June 30, 2022 | 1.726B |
| March 31, 2022 | 1.647B |
| December 31, 2021 | 1.089B |
| September 30, 2021 | 1.134B |
| June 30, 2021 | 1.145B |
| March 31, 2021 | 1.168B |
| December 31, 2020 | 1.220B |
| September 30, 2020 | 1.216B |
| June 30, 2020 | 1.290B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.161B |
| December 31, 2019 | 852.85M |
| September 30, 2019 | 873.84M |
| June 30, 2019 | 875.16M |
| March 31, 2019 | 879.85M |
| December 31, 2018 | 828.52M |
| September 30, 2018 | 798.94M |
| June 30, 2018 | 826.22M |
| March 31, 2018 | 915.87M |
| December 31, 2017 | 856.36M |
| September 30, 2017 | 823.27M |
| June 30, 2017 | 804.14M |
| March 31, 2017 | 810.37M |
| December 31, 2016 | 779.74M |
| September 30, 2016 | 913.30M |
| June 30, 2016 | 841.46M |
| March 31, 2016 | 767.35M |
| December 31, 2015 | 639.38M |
| September 30, 2015 | 635.29M |
| June 30, 2015 | 476.38M |
| March 31, 2015 | 426.42M |
| December 31, 2014 | 397.69M |
| September 30, 2014 | 381.70M |
| June 30, 2014 | 396.29M |
| March 31, 2014 | 419.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Eisai Co., Ltd. | 3.845B |
| Chugai Pharmaceutical Co., Ltd. | 2.598B |
| Santen Pharmaceutical Co., Ltd. | 717.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.958B |
| Shareholders Equity (Quarterly) | 1.123B |
| Debt to Equity Ratio | 1.26 |
| Current Ratio | 2.821 |
| Net Debt Paydown Yield | 2.08% |